SPIDIA for Personalized Medicine - Standardisation of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine

Project Information

SPIDIA4P

Grant agreement ID: 733112

DOI 10.3030/733112

Project closed

EC signature date 30 November 2016

Start date 1 January 2017

End date 30 June 2021

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 2 079 053,75

EU contribution € 1 999 972,50

Coordinated by

QIAGEN GMBH
Germany